Evaluation of clinical effects of oral tamsulosin in reducing urinary retention after spine surgery

Phase 3

• Conditions: rinary retention.; Bladder-neck obstruction; N32.0

• Registration Number: IRCT20140915019185N5
• Lead Sponsor: Mazandaran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age over 18 years
Male and female
Ability to complete the informed consent form to participate in the study
Accepting the schedule of participation in the study and the time of surgery and the fact that she must remain in the hospital for at least 1 night after surgery

Exclusion Criteria

Sensitivity or contraindication to the use of tamsulosin
Severe hypersensitivity to sulfa drugs
Use of the current alpha-blocker (alphazosin, doxazosin, prazosin, terazosin, verapamil, tamsulosin) or oral alpha agonists, or the initiation of any of these drugs during the start of the intervention phase of the study, which will cause the patient to drop out.
Take warfarin now
Use of a Foley catheter, suprapubic catheter or urostomy
Dialysis patients or patients with less than 200 cc of urine per day
Predicting the patient's inability to use the drug orally after surgery
Lack of conscious consent to participate in the study
Patients who use a Foley catheter chronically
Patients are expected to be transferred to the ICU after surgery.
Patients with a history of severe heart failure or major cardiovascular events in the past 6 months
Use beta-blockers, acetylcholinesterase inhibitors, or drugs that interfere with tamsulosin and betanacol.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary retention rate. Timepoint: 7 days before surgery and 0 to 2 days after surgery. Method of measurement: sonography.